News

The ninth annual Chancellor’s Diversity Forum provided a chance for UCSF faculty, staff and students to engage in a conversation with campus leadership about diversity, equity and inclusion across the University.

UCSF leaders are lauding the gift by Joan and Sanford I. Weill as transformational, giving the University an unprecedented opportunity to unite and expand its neurosciences community during a revolutionary period in brain discovery.

With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.

In the largest-ever gift to UCSF, the Weill Family Foundation and Joan and Sanford I. “Sandy” Weill have donated $185 million to establish the UCSF Weill Institute for Neurosciences.

Stem cell biologists at UCSF have demonstrated that IL-1 itself directly transforms the blood system by driving blood stem cells in the bone marrow to switch away from their restorative, rejuvenating role in blood renewal and towards emergency production of immune cells.

Global malaria eradication is possible within a generation, but only with renewed focus, new tools and sufficient financial support, according to a paper published in The Lancet by the Global Health Group’s (GHG) Malaria Elimination Initiative (MEI) at UC San Francisco (UCSF).

Time magazine has named internationally renowned breast cancer oncologist Laura Esserman to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

Frontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.

Graduate students Nairi Hartooni and Lindsey Osimiri have been named as recipients of the Paul & Daisy Soros Fellowship for New Americans.

UCSF neuroscientists Michael Brainard and John L.R. Rubenstein have been elected to the American Academy of Arts and Sciences.

The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.

UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.

The UCSF community is deeply saddened to learn about the passing of Richard Havel, MD, a world-renowned researcher in the field of lipoproteins and the former director of the UCSF Cardiovascular Research Institute.

It started with a small but persistent noise in her right ear. After other doctors failing to identify the source of the noise, clinicians at UCSF were able to inform the patient that she had a dural arteriovenous fistula in her right sigmoid sinus.

In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.

Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.

Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program, which includes a clinical arm, the UCSF Cancer Immunotherapy Clinic.

Clinicians at UCSF are taking on trauma as more than just a social issue. They are addressing how it has a staggering impact on a person’s health.

UCSF and UC Hastings College of the Law have combined their expertise to offer a new degree program: the Masters of Science program in Health Policy and Law, which begins classes in August.

Bruce Alberts has been named one of the 11 newly elected fellows of the American Association for Cancer Research.